如何操作:低剂量CT肺癌筛查中胸膜附着性肺结节的管理
本文综述低剂量CT肺癌筛查中胸膜附着性肺结节的术语、良性判断特征及证据准确性。平均直径小于10 mm、边缘光滑、呈三角形、透镜形、卵圆形或半圆形的胸膜附着实性结节良性可能性高。2019版Lung-RADS v1.1将其归为3类或4类并建议短期随访,而2022版Lung-RADS建议年度随访,将其降为2类并限制额外检查。
要点
- 胸膜附着性结节指距任何胸膜面距离为0 mm的结节,包括叶间裂、肋胸膜、纵隔胸膜和膈胸膜。
- 平均直径小于10 mm、边缘光滑、呈三角形、透镜形、卵圆形或半圆形的胸膜附着实性结节良性可能性高。
- 2022版Lung-RADS将具有上述特征的结节归为2类,建议年度随访而非短期随访。
核心结论
- 胸膜附着性实性结节若平均直径小于10 mm、边缘光滑且呈三角形、透镜形、卵圆形或半圆形,良性可能性高;2022版Lung-RADS将其降为2类并建议年度随访,限制了额外检查。
研究设计与样本
- 综述文章,总结胸膜附着性肺结节的术语、良性判断特征及支持推荐的证据准确性。
关键影像表现/征象
- 胸膜附着性结节定义为距任何胸膜面距离为0 mm的结节,可附着于叶间裂、肋胸膜、纵隔胸膜或膈胸膜。
- 平均直径小于10 mm、边缘光滑、呈三角形、透镜形、卵圆形或半圆形的胸膜附着实性结节良性可能性高。
诊断标准与关键数值
- 2019版Lung-RADS v1.1将具有上述良性特征的胸膜附着结节归为3类(可能良性,建议6个月随访)或4类(可疑恶性,建议3个月随访或PET/CT)。
- 2022版Lung-RADS建议年度随访而非短期随访,将此类结节降为2类(良性)并限制额外检查。
临床应用与阅片要点
- 阅片时识别胸膜附着性实性结节,评估平均直径是否小于10 mm、边缘是否光滑及形状是否为三角形、透镜形、卵圆形或半圆形。
- 依据2022版Lung-RADS,对具有上述良性特征的胸膜附着结节归为2类并建议年度随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Lung cancer is the leading cause of cancer deaths globally. In various trials, the ability of low-dose CT screening to diagnose early lung cancers leads to high cure rates. It is widely accepted that the potential benefits of low-dose CT screening for lung cancer outweigh the harms. The ability to reliably predict the benignity of nodules, especially at the baseline round, further reduces the potential for harm. Pleural-attached nodules are an important subgroup that represents nodules attached (distance from any pleural surface, 0 mm) to any pleural surfaces (fissural, costal, mediastinal, and diaphragmatic). Pleural-attached solid nodules less than 10 mm in average diameter with smooth margins and triangular, lentiform, oval, or semicircular shapes have a high likelihood of benignity. The 2019 Lung CT Screening Reporting and Data System (Lung-RADS) version 1.1 assigned pleural-attached nodules with these features to categories 3 (probably benign, recommend follow-up in 6 months) or 4 (suspicious for malignancy, recommend follow-up in 3 months or PET/CT). However, Lung-RADS version 2022 now recommends annual follow-up rather than short-term follow-up. These changes downgrade these nodules to category 2 (benign) and limits additional workup. This review article summarizes the terminology used to describe these nodules, characteristics for determining benignity, and the accuracy of the evidence used to make these recommendations.
引用
- Zhu Y, Yankelevitz DF, Henschke CI, et al. How I Do It: Management of Pleural-attached Pulmonary Nodules in Low-Dose CT Screening for Lung Cancer. Radiology. 2025. PMID: 39835978. doi:10.1148/radiol.240091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。